MwanzoLILY34 • BVMF
add
Eli Lilly And Company BDR
Bei iliyotangulia
R$ 185.05
Bei za siku
R$ 181.06 - R$ 186.04
Bei za mwaka
R$ 112.71 - R$ 208.36
Thamani ya kampuni katika soko
977.11B USD
Wastani wa hisa zilizouzwa
elfu 19.51
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Financial Times
saa 10 zilizopita
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss
1.20%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 17.60B | 53.87% |
Matumizi ya uendeshaji wa biashara | 6.09B | 29.12% |
Mapato halisi | 5.58B | 475.34% |
Kiwango cha faida halisi | 31.72 | 274.06% |
Mapato kwa kila hisa | 7.02 | 494.92% |
EBITDA | 8.97B | 78.81% |
Asilimia ya kodi ya mapato | 22.81% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 9.91B | 181.76% |
Jumla ya mali | 114.94B | 52.02% |
Jumla ya dhima | 91.08B | 48.62% |
Jumla ya hisa | 23.85B | — |
hisa zilizosalia | 895.38M | — |
Uwiano wa bei na thamani | 6.97 | — |
Faida inayotokana na mali | 19.69% | — |
Faida inayotokana mtaji | 34.07% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 5.58B | 475.34% |
Pesa kutokana na shughuli | 8.84B | 138.04% |
Pesa kutokana na uwekezaji | -2.98B | 25.52% |
Pesa kutokana na ufadhili | 531.00M | 151.30% |
Mabadiliko halisi ya pesa taslimu | 6.42B | 4,312.65% |
Mtiririko huru wa pesa | 2.22B | 256.60% |
Kuhusu
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 11th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1876
Makao Makuu
Tovuti
Wafanyakazi
47,000
